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Introduction
The extracellular matrix (ECM), present between cells, is
the authentic substrate for most cells in living organisms.
Interplay between the ECM and cells plays a critical role in
regulating cell differentiation, proliferation, apoptosis, and
matrix synthesis. A substantial characteristic of hyaline
cartilage is that a few chondrocytes, which are the sole
cells in this tissue, are surrounded by the abundant ECM.
Therefore, the ECM is considered to be a key regulator of
cartilage development and regeneration.
The limited potential of articular cartilage to self-repair
leads to the demand for surgical procedures to treat
symptomatic cartilaginous lesions. However, no previous
procedures have successfully provided long-lasting hyaline
cartilage repair for such lesions. On the other hand, carti-
lage tissue engineering or autologous chondrocyte
implantation (ACI) is expected to be an ideal procedure for
cartilaginous lesions [1, 2]. Tissue engineering techniques
basically comprises three key factors including scaffolds,
cells, and signals. Among these factors, a number of studies
have emphasized the importance of selecting suitable
biomaterials as scaffolds for cell adhesion, proliferation,
and ECM production [2–9]. For the reason mentioned in
the first paragraph, scaffolds for cartilage regeneration are
especially required to provide the functional role of tissue-
specific ECM.
Scaffold criteria for cartilage tissue engineering
Scaffolds for articular cartilage regeneration should have
the potential to both withstand a mechanically stressed
environment, and to support chondrogenesis while main-
taining the chondrocyte phenotype. To meet those
requirements, the following criteria must be considered in
developing cartilage tissue engineering scaffolds: (1) bio-
compatibility with no or minimal inflammation; (2) non-
cytotoxity; (3) biodegradability; (4) three-dimensional (3-
D) structure; (5) adequate void space for cell infiltration,
proliferation, ECM production, and nutrient diffusion; (6)
high cellular adhesivity; (7) appropriate mechanical
strength in living joints; and 8) versatility for implanting
into a variety of lesion shapes and sizes [10].
Types and design of scaffold biomaterials for cartilage
tissue engineering
Scaffold biomaterials include both naturally occurring and
synthetic materials. Unfortunately, each type of material
has characteristic disadvantages. The major limitations of
naturally occurring materials are due to the immunoge-
nicity and the lot-to-lot variability in molecular structure
associated with animal sourcing. In contrast, synthetic
materials have a greater potential for toxicity and chronic
inflammation than occurs with natural materials.
Additionally, scaffold biomaterials for cartilage regen-
eration can be classified into four categories as follows:
protein-based materials (fibrin, gelatin, collagen, etc.),
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carbohydrate-based materials (agarose, polylactic acid,
polyglycolic acid, hyaluronan, alginate, chitosan, etc.),
synthetic/artificial polymer-based materials, and combined
materials [10]. Regarding available shapes of the scaffolds,
there are three main categories of shapes used in cartilage
tissue engineering, including membranes/sheets, gels/
foams, and 3-D fabricated matrices.
Current procedures for cartilage regeneration are based
on three main approaches: (1) cultured cell implantation,
(2) engineered tissue implantation, or (3) guided tissue
regeneration. To achieve cartilage regeneration success-
fully, the selection of biomaterials and shapes for deter-
mining scaffold designs must be based on the targeted
approach intended to be used by surgeons.
Strategic scaffold designs based on approach
for cartilage regeneration
Scaffolds for cultured cell implantation
Since the first clinical report by Brittberg et al. [1], ACI has
been the most widely performed cartilage tissue regenera-
tion technique. In the first report, the authors cultured the
isolated chondrocytes in a suspension medium. The cul-
tured cells were then implanted into the chondral lesion of
the knee without any specific carrier materials. The defect
filled with suspension containing chondrocytes was cov-
ered with a periosteal flap harvested from the proximal
tibia. Their results suggest that ACI restores joint function
by forming predominantly hyaline-like cartilage containing
type II collagen.
Among the scaffolds used for cartilage tissue engineer-
ing, hydrogels are considered to be a suitable scaffold and
cell carrier for cultured cell implantation. These materials
promote chondrocyte adhesion in a manner that mimics the
cartilage ECM and maintains the chondrocyte phenotype in
a way that is unachievable in a monolayer culture system
[11–15]. Additionally, their viscoelasticity effectively
transduces mechanical signals to embedded chondrocytes
for control of cellular activities. In terms of carrier func-
tions, hydrogels can easily adopt a variety of shapes and
sizes of cartilaginous lesions. However, most of the
hydrogels clinically used require periosteal coverage over
the lesion to prevent the leakage of implanted cells, leading
to open surgery.
Towards a less invasive procedure, several authors
applied a 3-D hyaluronan-based scaffold (Hyalograft C) to
perform arthroscopic ACI for the treatment of cartilaginous
lesions in the knee [16, 17]. This method, which does not
need periosteal coverage, has potential for reducing patient
morbidity, operation time, and treatment cost. Techniques
based on the usage of such hydrogels will allow less
invasive surgery for cartilage regeneration.
Scaffolds for engineered tissue implantation
In articular cartilage tissue engineering, we must consider
that the articular surface is subject to excessive mechanical
stress. The severe mechanical conditions result in dedif-
ferentiation of the implanted chondrocytes, degeneration of
the regenerated tissues, and roughness of the tissue surface.
To overcome these considerations, a reasonable approach
is to transplant mechanically and histologically mature
engineered cartilage into cartilaginous lesions. This
approach probably necessitates a long-term culture period
in a bioreactor system, which provides appropriate nutri-
tion and mechanical stimulation for the seeded cells.
Consequently, scaffolds have to maintain the initial shape
against applied mechanical stress and accelerate chondro-
genesis during the culture period.
To meet these requirements, Yamane et al. [18] have
developed a novel 3-D scaffold fabricated from chitosan-
based hyaluronic acid (HA) hybrid polymer fibers. The
authors demonstrated that these hybrid polymer fibers have
superior adhesivity of chondrocytes and the capability to
maintain chondrocyte phenotype. These fibers also main-
tained the initial shape of the 3-D scaffold during cultiva-
tion and enhanced cartilage tissue regeneration in vitro.
Regarding the pore size of the fabrication, Yamane et al.
[19] suggested that a relatively large size of 400 um sig-
nificantly increased the ECM synthesis by cultured
chondrocytes.
Based on the data obtained from these in vitro studies,
Kasahara et al. [20] and Iwasaki et al. [21] created two
different types of scaffolds fabricated from the novel
hybrid polymer fibers. One was a cushion-type scaffold
consisting of two sheets (Fig. 1a), the other was a cylinder-
type scaffold (Fig. 1b). To prepare tissue-engineered con-
structs, a chondrocyte suspension containing 3 9 105 and
7 9 105 cells isolated from 8 week-old Japanese white
rabbits was seeded onto the cushion-type (cushion group)
and the cylinder-type (cylinder group) scaffolds, respec-
tively. After 1-week static culture, each sample was
dynamically cultured in a disposable, high aspect ratio
vessel bioreactor (HARV, 50 ml; Synthecon, Inc., Hous-
ton, Tx, USA) for a further 4 or 7 weeks. Table 1 sum-
marizes biochemical and biomechanical assessments of
engineered cartilage at each time point [20]. Macroscopic
(Fig. 2) and histological (Fig. 3) findings at 8 weeks after
cultivation showed hyaline-like cartilage regeneration with
abundant GAG and type II collagen products [20].
Regarding the mechanical property of engineered cartilage,
the cushion-type scaffold significantly increased the
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Fig. 1 Three-dimensional (3-D) scaffolds fabricated from chitosan-
based hyaluronic acid (HA) hybrid polymer fibers. a Cushion-type
(8 9 8 mm wide and 1 mm thick); b cylinder type (10 mm high and
6 mm diameter. The pore size of both scaffolds is 400 lm [21].
Reproduced with permission of Iwasaki N, Kasahara Y, Yamane S,
Igarashi T, Minami A, Nishimura S-I. Chitosan-based hyaluronic acid
hybrid polymer fibers as a scaffold biomaterial for cartilage tissue
engineering. Polymers 2011;3:100–13
Table 1 Biochemical and biomechanical assessments of engineered cartilage in both materials [20]
Cushion-type Cylinder-type
5 weeks 8 weeks 5 weeks 8 weeks
Total amount of DNA (lg) 53.8 ± 1.4 95.5 ± 2.1* 97.9 ± 3.2 132.3 ± 6.6
Total amount of protein (lg) 1108.4 ± 49.3 2178.9 ± 114.5* 1655.9 ± 82.9 2677.5 ± 356.0
Protein/DNA ratio 20.9 ± 1.7 22.9 ± 2.5 17.0 ± 1.0 20.1 ± 1.9
Young’s modulus (MPa) 4.9 ± 1.1 12.2 ± 2.4*,** 2.8 ± 0.5 3.2 ± 0.7
Mean ± standard error. N = 5 in each group
Reproduced with permission of Kasahara Y, Iwasaki N, Yamane S, Igarashi T, Majima T, Nonaka S, Harada K, Nishimura S, Minami A.
Development of mature cartilage constructs using novel three-dimensional porous scaffolds for enhanced repair of osteochondral defects.
J Biomed Mater Res A 2008;86:127–36
* p \ 0.01 vs. 5 weeks,  p \ 0.05 vs. 5 weeks, ** p \ 0.001 vs. Cylinder-type scaffold at 8 weeks
Fig. 2 In vitro macroscopic
appearance of engineered
cartilage in each scaffold at
8 weeks after cultivation. a,
b Cushion-type; c, d cylinder-
type [20]. Reproduced with
permission of Kasahara Y,
Iwasaki N, Yamane S, Igarashi
T, Majima T, Nonaka S, Harada
K, Nishimura S, Minami A.
Development of mature
cartilage constructs using novel
three-dimensional porous
scaffolds for enhanced repair of
osteochondral defects. J Biomed
Mater Res A 2008;86:127–36
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Young’s modulus from 5 to 8 weeks after cultivation.
Although the modulus of the cylinder group was signifi-
cantly inferior to that of the cushion group, the value was
comparable to that of normal cartilage in rabbits. These
results suggested that the developed 3-D scaffolds regen-
erated mature tissue close to articular hyaline cartilage.
Then, the mature tissue-engineered cartilage using each
scaffold was press-fit implanted into the osteochondral
defects (5 mm in diameter and 2 mm deep) on the patellar
groove of mature Japanese white rabbits (2.6–3.1 kg
weight). For postoperative evaluations, animals were
euthanized at 12 weeks postoperatively and the femoral
condyles were harvested. The macroscopic appearance of
osteochondral defects showed a repair with cartilage-like
tissue in both scaffold groups over the no treatment group
(Fig. 4) [20, 21]. Histological findings also demonstrated
that the defects in both scaffold groups were repaired with
hyaline-like cartilage or a combination of hyaline-like
cartilage and fibrocartilage (Fig. 5) [20]. The histological
scores according to the criteria of Wayne [22] and the
Young’s modulus as a mechanical property of both scaffold
groups significantly improved, compared to those of the no
treatment group (Table 2) [20]. There were no statistically
significant differences in the Young’s modulus between the
reparative tissue of both scaffold groups and normal
cartilage.
The authors succeeded in regenerating mature hyaline-
like cartilage using the novel fabricated 3-D scaffold
in vitro. The implantation of the engineered tissue plays
functional roles in repairing osteochondral defects in living
joints.
Scaffolds for guided tissue regeneration
To date, a number of studies have demonstrated favorable
clinical outcomes of ACI procedures for the treatment of
cartilaginous lesions [1, 23]. However, prospective ran-
domized trials have not clearly suggested dominance of
this procedure over other operations for such lesions [24,
25].
A possible reason for the unsatisfactory outcomes is the
adverse effects resulting from the invasive procedures
involved in the current ACI technique, which is based on a
two-stage operation, the first stage to harvest cartilage
tissue to isolate chondrocytes, and the second stage to
implant cultured chondrocytes into the cartilaginous lesion.
Fig. 3 In vitro histological and immunohistochemical findings of
engineered cartilage in each scaffold at 8 weeks after cultivation. a–
c Cushion-type; d–f cylinder-type. Hematoxylin and eosin staining
reveals that cultured cells are distributed throughout the entire
scaffolds (a, d). Safranin-O staining indicates the production of a
proteoglycan-rich cartilaginous matrix (b, e). Immunohistochemical
staining with antitype II collagen shows the abundant production of
type II collagen (c, f). Scale bars indicate 5 mm [20]. Reproduced
with permission of Kasahara Y, Iwasaki N, Yamane S, Igarashi T,
Majima T, Nonaka S, Harada K, Nishimura S, Minami A. Develop-
ment of mature cartilage constructs using novel three-dimensional
porous scaffolds for enhanced repair of osteochondral defects.
J Biomed Mater Res A 2008;86:127–36
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These processes may result in donor site morbidity,
dedifferentiation of cultured chondrocytes, and cost inef-
fectiveness. Our technique for engineered tissue
implantation mentioned above also faces these limitations.
On the other hand, guided tissue regeneration is a cell-free
approach involving the implantation of naturally occurring
Fig. 4 Macroscopic appearance of osteochondral defects at 12 weeks
after operation. The obtained findings demonstrate a repair with
cartilage-like tissue in the cushion-type (b) and the cylinder-type
(c) treatment groups over the no treatment group (a) [21]. Reproduced
with permission of Iwasaki N, Kasahara Y, Yamane S, Igarashi T,
Minami A, Nishimura S-I. Chitosan-based hyaluronic acid hybrid
polymer fibers as a scaffold biomaterial for cartilage tissue engineer-
ing. Polymers 2011;3:100–13
Fig. 5 Histological and immunohistochemical findings of reparative
tissues in each scaffold at 12 weeks after operation. a, d No treatment
group; b, e cushion-type group; c, f cylinder-type group. Safranin-O
staining (a–c) and immunohistochemical staining with antitype II
collagen (d–f) indicate a repair with hyaline-like cartilage in both the
cushion-type and the cylinder-type treatment groups. Scale bars
indicate 1 mm [20]. Reproduced with permission of Kasahara Y,
Iwasaki N, Yamane S, Igarashi T, Majima T, Nonaka S, Harada K,
Nishimura S, Minami A. Development of mature cartilage constructs
using novel three-dimensional porous scaffolds for enhanced repair of
osteochondral defects. J Biomed Mater Res A 2008;86:127–36
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or synthetic scaffolds into the cartilage defects to com-
plement natural biological repair [10]. This approach
shows great potential for overcoming the above limitations
of the current ACI technique.
To perform guided tissue regeneration, Igarashi et al.
[26] developed an in situ forming gel based on alginate as
an injectable material. This naturally occurring material
was ultrapurified by an original technique to reduce dras-
tically its endotoxity. The previous study has demonstrated
that the ultrapurified alginate gel (UPAL gel) has favorable
biological effects on in vitro proliferation and chondro-
genesis of bone marrow stromal cells (BMSCs) [26]. In
addition, the previous in vivo studies using rabbits and
canines have shown that implantation of autologous
BMSCs using the UPAL gel enhanced cartilage repair in
cartilaginous lesions [26, 27]. Furthermore, the results
obtained from these studies indicate that the acellular
UPAL gel implantation technique has the potential to
repair osteochondral defects by effectively recruiting host
BMSCs.
Stromal cell-derived factor-1 (SDF-1)/pre-B cell
growth-stimulating factor, belonging to the CXC subfamily
of chemokines, is a critical chemokine for stem cells
homing to bone marrow in the repair of injured tissues.
Table 2 Quantitative assessments of reparative tissue at 12 weeks
postoperatively [20]
No
treatment
Cushion-
type
Cylinder-
type
Normal
cartilage
Histological
score
5.3 ± 0.7 10.1 ± 1.4* 9.3 ± 1.6** /
Young’s
modulus
(MPa)
10.4 ± 3.8 1.9 ± 0.6 1.7 ± 0.6 3.2 ± 0.6
Mean ± standard error. N = 7 in each group
Reproduced with permission of Kasahara Y, Iwasaki N, Yamane S,
Igarashi T, Majima T, Nonaka S, Harada K, Nishimura S, Minami A.
Development of mature cartilage constructs using novel three-
dimensional porous scaffolds for enhanced repair of osteochondral
defects. J Biomed Mater Res A 2008;86:127–36
* p \ 0.001 vs. no treatment, ** p \ 0.005 vs. no treatment
Fig. 6 Histological findings of reparative tissues at 16 weeks after
operation. a–d Safranin-O staining; e–h immunohistochemical stain-
ing with anti-type I collagen antibody; i–l immunohistochemical
staining with anti-type II collagen antibody. Defect, no treatment;
Vehicle, UPAL gel containing 10 lg/ml bovine serum albumin; SDF-
1, UPAL gel containing 10 lg/ml SDF-1 (Miltenyi Biotec Inc.,
Auburn, CA, USA); and AMD3100, UPAL gel containing 250 lg/ml
AMD3100, an antagonist of CXCR4, (Sigma-Aldrich, Saint Louis,
MO, USA). Scale bar: 1 mm. The SDF-1 group indicates a repair with
the hyaline-like cartilage and normal subchondral bone structures
[29]. Reproduced with permission of Sukegawa A, Iwasaki N,
Kasahara Y, Onodera T, Igarashi T, Minami A. Repair of rabbit
osteochondral defects by an acellular technique with an ultrapurified
alginate gel containing stromal cell-derived factor-1. Tissue Eng Part
A 2012;18:934–45
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Unlike other chemokines, SDF-1 is unique in that it binds
only to its receptor, CXCR4. Regarding musculoskeletal
tissues, Shimode et al. [28] demonstrated that a local
upregulation of SDF-1 after ligament injuries enhanced the
homing of BMSCs to the injured site in a rat experimental
model. Consequently, the author hypothesized that the
local administration of UPAL gel containing SDF-1 could
enhance the repair of osteochondral defects by recruiting
host BMSCs to the defect site.
The in vivo study using a rabbit model demonstrated the
positive chemotactic effect of SDF-1 on the homing of host
cells to osteochondral defects [29]. Additionally, the acel-
lular implantation of UPAL gel containing SDF-1
enhanced the reparative process of cartilaginous lesions
histologically (Fig. 6) and biomechanically (Table 3) [29].
In conclusion, the author successfully achieved hyaline-
like cartilage repair by local administration of SDF-1 using
UPAL gel without cultured cells. The obtained results
show potential for tissue guided regeneration using the
novel hydrogel in the treatment of cartilaginous lesions.
Further studies will clarify the clinical indications for this
technique, including cartilage defect and patient factors.
Future trends
Cartilage tissue engineering or ACI has been clinically
applied to cartilaginous lesions in the treatment of a variety
of disorders and trauma. However, as mentioned above, the
expected efficacy of this procedure has not been achieved
in prospective randomized trials [24, 25]. To improve the
clinical outcomes, we need to develop novel scaffolds for
cartilage regeneration. Especially, future studies on bio-
materials for cartilage tissue engineering will focus on the
following considerations.
First, acellular scaffold-based techniques combined with
chemokines or bone marrow stimulating techniques must
be established for a one-step surgery. Second, arthroscopic
techniques using in situ forming materials without perios-
teal coverage are required to achieve a minimally invasive
surgery for cartilage regeneration. The attainment of these
goals will eliminate morbidity, lessen the high cost and
complicated logistics related to cell culture, and lead to
improved clinical outcomes for cartilage regenerative
medicine. Third, scaffolds which can maintain well-dif-
ferentiated chondrocytes should be developed to regenerate
mature hyaline-like cartilage. To accomplish this, the
fundamental biomaterials for scaffolds require functions to
eliminate dedifferentiated chondrocytes from the culture
system and enhance the chondrogenesis of stem cells, such
as BMSCs or iPS cells. Finally, scaffolds for engineering
entire osteochondral units should be created. In clinical
fields, most articular cartilaginous lesions are associated
with subchondral bone defects. Therefore, an ideal treat-
ment strategy is needed for not only cartilage repair, but
also osteochondral repair.
Conclusions
Currently, the clinical application of cartilage tissue engi-
neering or ACI to patients with osteochondral defects has
surpassed 20 years. Although this innovative technique
must be an ideal one for the treatment of cartilaginous
lesions, previous clinical studies have not clearly demon-
strated significant superiority of its postoperative outcomes
over other operations [24, 25]. To achieve better outcomes
of current cartilage tissue engineering or ACI techniques,
there is still room for improvement in the clinically
available scaffolds. The final goals of this treatment must
be to enhance hyaline-like cartilage repair and to establish
minimally invasive techniques. The application of novel
developed scaffolds will play a crucial role in achieving
these goals.
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